Maternal outcome in eclampsia at Harare Maternity Hospital

Central African Journal of Medicine

Volumn 47, Issue 5, 2001, Pages 123-128

  Majoko, F ^a,b   Mujaji, C ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CROSS-SECTIONAL STUDY; ECLAMPSIA; FEMALE; HUMAN; MATERNAL MORTALITY; MORTALITY; PREGNANCY; RISK; TREATMENT OUTCOME; ZIMBABWE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; ECLAMPSIA; FEMALE; HUMANS; MATERNAL MORTALITY; PREGNANCY; RISK; TREATMENT OUTCOME; ZIMBABWE;

EID: 0035352998     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: 10.4314/cajm.v47i5.8602     Document Type: Article

References (22)

1. World Health Organization. Revised 1990 estimates of maternal mortality. A new approach by WHO and UNICEF, Document WHO/FRH/MSM/96.11, UNICEF/PLN/96.1. Geneva: WHO, 1996.
2. Greater Harare Maternity Unit. Maternal Mortality Report. 1997 (unpublished institutional report).
3. Arora R, Ganguli R P, Swain S, Oumachigui A, Rajaram P. Determinants of maternal mortality in eclampsia in India. Aust NZ J Obstet Gynaecol 1994;34: 537-9.
4. Mwinyoglee J, Amoko D H A, Simelela N, Marivate M. Eclampsia at Ga- Rankuwa Hospital. S Afr Med J 1996;86:1536-9.
5. Douglas K A, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309:1395-1400.
6. Konje JC, Obisesan KA, Odukoya OA, Ladipo OA. Presentation and management of eclampsia. Int J Gynecol Obstet 1992;38:31-5.
7. Moodley J, Daya P. Eclampsia: a continuing problem in developing countries. Int J Gynecol Obstet 1993;44:9-14.
8. Ogunniyi SO, Sanusi YO, Ogunniyi FA. Eclampsia: a continuing obstetric catastrophe-the experience in Ile-Ife, Nigeria. J Obstet Gynaecol 1999;19:26-29.
9. Taner CE, Hakverdi AU, Aban M, Erden AC, Ozelbaykal U. Prevalence, management and outcome in eclampsia. Int J Gynecol Obstet 1996;53:11-15.
10. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 1990;97:110-17.
11. Greater Harare Maternity Unit. Perinatal Mortality Report. 1997 (unpublished institutional report).
12. Obed SA, Wilson JB, Elkins TE. Eclampsia: 134 consecutive cases. Int J Gynecol Obstet 1994,45:97-103.
13. Crowther C A. Eclampsia at Harare Maternity Hospital. An epidemiological study. S Afr Med J 1985;68:927-9.
14. Moller B, Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand 1986;65:307-14.
15. Sibai, B M. Eclampsia VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049-55.
16. Crowther C A. Management and pregnancy outcome in eclampsia at Harare Maternity Hospital. Cent Afr J Med 1985;31:107-109.
17. Abi-Said D, Annegers JF, Combs-Cantrell D, Suki R, Frankowski RF, Willmore L J. A case-control evaluation of treatment efficacy: the example of magnesium sulfate prophylaxis against eclampsia in patients with preeclampsia. J Clin Epidemiol 1997;50:419-23.
18. Odendaal H J, Hall D R. Is magnesium sulfate prophylaxis really necessary in patients with severe pre-eclampsia? J Matern Fetal Invest 1996;6:14-18.
19. Duley L, Neilson JP. Magnesium sulphate and preeclampsia BMJ 1999;319: 3-4.
20. Breen M. Eclampsia - what is the best treatment? Postgrad Doctor Africa 1996;18:41-8.
21. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborating Eclampsia Trial. Lancet 1995;345:1455-63.
22. Arora R, Swain S, Agrawal A, Habeebullah S. Impact of mode of delivery on maternal mortality in eclampsia. J Ind Med Assoc 1997;95:103-4.